Companies / VivArt-X
VivArt-X
Company
VivArt-X is focussing on women’s health and offers a revolutionary synthetic, degradable biomaterial for personalized breast reconstruction and regeneration.
VivArt-X has 2 investors on file, among them Borski Fund and StartGreen Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Borski Fund
19 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (28%), AI & Machine Learning (21%), Industrial & Manufacturing (17%).
More from StartGreen Capital
4 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (50%), Industrial & Manufacturing (17%), Fintech (17%).
See StartGreen Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get VivArt-X and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Borski Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/vivart-x.com/investors
# also
GET /v1/companies/vivart-x.com
GET /v1/companies/vivart-x.com/news